医院门诊用药错误及其防范

来源 :药物不良反应杂志 | 被引量 : 0次 | 上传用户:tangtang132
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
目的:分析首都医科大学附属北京同仁医院门诊用药错误(ME)的发生情况,探讨 ME的有效防范措施。方法首都医科大学附属北京同仁医院作为参与北京市卫生局 ME 监测报告系统试运行的医院,自2011年8月上报 ME 报告,并在医院内按月进行 ME 报告分析,根据分析结果制定防范措施。收集门诊药房2011年8月至2013年3月上报北京市卫生局的 ME 报告,进行 ME 分级(按美国国家用药错误报告及预防协调委员会标准)和发生环节分析,分2011年8月至2012年9月(北京市 ME 监测报告系统试运行阶段)和2012年10月至2013年3月(全国临床安全用药监测网络运行阶段)2个时段进行 ME 发生情况比较,评价医院所制定防范措施的有效性。结果共收集到ME 报告506例,占同期门诊处方例数的0.031%(506/1636429)。A 级错误(错误隐患)2例,B 级错误(发生错误但未发给患者,或已发给患者但未使用)462例,C 级错误(患者已使用,但未造成伤害)42例,无 D ~ I 级错误。ME 发生在医师处方环节者459例,主要为用法用量不当(75.16%,345/459)、给药途径不当(12.64%,58/459)、选药不当(5.88%,27/459)、有禁忌证用药(3.05%,14/459)、配伍不当(2.61%,12/459)及溶媒不适宜(0.65%,3/459);发生在药师调配环节者47例,导致错误的主要原因有名称相似、包装相似及位置相邻等。针对医师处方环节,医院自2012年10月启动“四级点评、四级反馈”的监管模式,有效提高了处方合格率,医师处方环节的 ME 例数占同期处方例数的比例由试运行阶段的0.035%(398/1139613)降至运行阶段的0.012%(61/496816)。针对药师调配环节,采取多种方法提高易混淆药品的辨识度,药师调配环节的 ME 发生率由试运行阶段的0.004%(40/1139613)降至运行阶段的0.001%(7/496816)。结论首都医科大学附属北京同仁医院门诊 ME 以 B 级和 C 级错误为主,主要发生在医师处方环节,主要错误类型为药物用法用量不当。“四级点评、四级反馈”的监管模式可有效防范医师处方环节的 ME。“,”Objective To analyze the status of medication error(ME)of outpatient pharmacy of Beijing Tongren Hospital Affiliated to Capital Medical University and to find effective prevention and control measures. Methods As a pilot run hospital of Beijing Municipal Health Bureau ME monitoring system, ME cases were reported since August 2011 by the hospital and ME reports were analyzed monthly to formulate prevention measures. ME cases of outpatient pharmacy,which were reported to Beijing Municipal Health Bureau,from August 2011 to March 2013 were collected. The ME cases were classified according to the ME classification standard of The National Coordinating Council for Medication Error Reporting and Prevention and the links in which ME cases occurred were analyzed. MEs that occurred from August 2011 to September 2012(the pilot operation stage of the Beijing ME monitoring system)were compared with those from October 2012 to March 2013( the operation stage of Beijing municipal bureau of clinical medication safety monitoring network). The effectiveness of prevention measures was evaluated. Results A total of 506 ME cases,accounting for 0. 031%(506 / 1 636 429)of the number of outpatient prescriptions at the same time,were collected. There were 2 cases of category A( potential error problems),462 cases of category B(errors happened but the drug was not given to patient,or the drug had been given to patient but was not taken),42 cases of category C( patients had used the drug but not be harmed),and none of categories D-I. Among them,459 ME cases occurred in the links of prescriptions by doctors including improper usage and dosage(75. 16% ,345 / 459),improper administration route(12. 64% ,58 / 459), improper drug selection(5. 88% ,27 / 459),taking medication within comtraindication(3. 05% ,14 / 459), imcompatibility(2. 61% ,12 / 459),and improper choice of solvents(0. 65% ,3 / 459). Forty-seven ME cases occurred in the links of dispensing prescriptions by pharmacists including sound alike,look alike, adjacent locations,and so on. Aiming to the links of doctors making prescriptions,a supervision model of“ four-grade prescription comment and four-grade feedback” was carried out since October 2012 and the rate of qualified prescriptions was increased effectively. The proportion of ME cases in the links of prescriptions by doctors in all the prescription cases during the same period decreased from 0. 035%(398 / 1 139 613)in the pilot operation stage to 0. 012%(61 / 496 816)in the operation stage. Aiming to the links of dispensing prescriptions by pharmacists,many kinds of measures were carried out to improve the identification of easily confused drugs. The incidence of ME in the links of dispensing prescriptions by pharmacists decreased from 0. 004%(40 / 1 139 613)in the pilot operation stage to 0. 001%(7 / 496 816)in the operation stage. Conclusion The ME cases in outpatient pharmacy of Beijing Tongren Hospital Affiliated to Capital Medical University were mainly category B and C and mostly occurred in the links of prescriptions by doctors. The main type of ME was usage and dosage. The supervision model of “ four-grade prescription comment and four-grade feedback” could effectively prevent the ME in the links of prescriptions by doctors.
其他文献
期刊
@@
肌微管素相关蛋白(Myotubularin-related protein)家族是广泛存在于人类的一大类脂质脱磷酸作用的蛋白,作用涉及代谢,自噬,肿瘤增殖等,但目前研究尚少,很多具体机制并不清楚.
目的探讨序贯性血液净化[血液灌流(HP)+连续性静脉-静脉血液滤过(CVVH)]对急性有机磷农药中毒(AOPP)患者心功能的影响及其应用价值。方法以45例重症AOPP并中毒性心肌炎患者为研究对象,按随机数字表法分为对照组22例,给予常规内科治疗+HP;治疗组23例,给予常规内科治疗和HP+CVVH。观察两组患者治疗前及治疗后24,48,72 h,各时点左室射血分数(LVEF)、血浆B型脑钠肽(BN
目的探讨外伤性颈动脉海绵窦瘘(TCCF)导致的动眼神经麻痹(ONP)经血管内球囊栓塞治疗后动眼神经功能恢复时间的影响因素。方法回顾性分析76例TCCF导致的ONP患者的临床资料,所有患者均接受血管内球囊栓塞治疗。采用非参数检验进行ONP恢复时间影响因素的单因素分析,采用多元线性回归分析做多因素分析。结果76例术后即刻造影显示瘘口完全闭塞,73例(96.1%)患者保留颈内动脉。术后随访6~70个月,
目的评价在右美托咪定镇静状态下进行局部麻醉义眼台置换术临床效果及安全性。方法32例术前15 min静脉滴注右美托嘧定(1.0 μg/kg),10~15 min滴注完毕,达到Ramsay镇静VI级后,再用0.75%罗哌卡因与2%利多卡因等量混合,分别行患眼球后及结膜下麻醉,检查患者反应恢复到Ramsay镇静Ⅲ级后开始手术操作并维持右美托咪定静脉滴注。结果全组32例术中均无疼痛感并能很好配合手术,术后
对腹足纲软体动物罗曼蜗牛Helix pomatia的氧运输蛋白(βC-血清蛋白)的功能单位e中的碳水化合物进行了研究.以该βC-血清蛋白为载体,通过限制性胰蛋白酶水解,产生片段a-c,ef,
期刊
@@
带状疱疹后神经痛属于带状疱疹中特别普遍的慢性并发症,得这种病最多的人群就是老年人,疼痛比较顽固,严重影响了他们的生活品质,现阶段带状疱疹后神经痛治疗的主要方向就是修
目的观察吸烟支气管哮喘患者吸入小剂量糖皮质激素联合茶碱治疗的疗效。方法选取门诊支气管哮喘患者73例,其中吸烟患者34例(观察组),非吸烟患者39例(对照组)。两组患者给予布地奈德气雾剂200 μg/吸,2吸/d;口服氨茶碱片0.1 g/次,3次/d,疗程3个月。比较两组基本控制率及治疗前后哮喘控制测试(ACT)评分、呼气峰流速(PEF)、第1秒用力呼气容积占预计值百分比(FEV1%预计值)、外周血
目的评价雷珠单抗(Ranibizumab)玻璃体内注射治疗常规老年性白内障术后人工晶状体眼顽固性囊样黄斑水肿的效果。方法此类顽固性囊样黄斑水肿接受雷珠单抗玻璃体内注射治疗5例,随访3~6个月。对比治疗前后视力、黄斑部视网膜形态及厚度。结果经1次治疗后,视力均明显提高,黄斑部视网膜水肿消失,无水肿复发,无并发症发生。结论雷珠单抗治疗常规老年性白内障术后顽固性囊样黄斑水肿是安全而有效的。